Amit K. Verma, M.B.,B.S.

Medicine

Phone718-430-8761
Emailamit.verma@einsteinmed.org
Websitehttp://www.einstein.yu.edu/faculty/10065/amit-verma/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Amit K. Verma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
5 Finished

Therapeutic targeting of MDS stem cells
Steidl, U. G. & Verma, A. K.
National Heart, Lung, and Blood Institute
8/20/18 → 6/30/21
Project: Research project
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Verma, A. K.
1/1/19 → 6/30/20
Project: Research project
Therapeutic targeting of glutamine metabolism in MDS
Verma, A. K. & Verma, A. K.
4/1/16 → 3/31/21
Project: Research project
Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes
Verma, A. K. & Verma, A. K.
National Institute of Diabetes and Digestive and Kidney Diseases
9/1/14 → 5/31/18
Project: Research project
The role of Dock4 in normal and aberrant erythropoiesis
Verma, A. K., Wickrema, A., Verma, A. K., Rose, S. A., Rose, S. A., Rose, S. A. & Rose, S. A.
National Heart, Lung, and Blood Institute
9/26/12 → 6/30/17
Project: Research project

8990 Citations
56 h-Index
171 Article
29 Review article
16 Letter
9 Comment/debate
More
- 3 Chapter

Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML
Jasra, S., Kazemi, M., Shah, N., Chen, J., Fehn, K., Wang, Y., Mantzaris, I., Kornblum, N., Sica, A., Bachier, L. M., Goldfinger, M., Gritsman, K., Braunschweig, I., Steidl, U., Shastri, A. & Verma, A., Dec 2021, In: Experimental Hematology and Oncology. 10, 1, 1.
Research output: Contribution to journal › Letter › peer-review

Open Access
Efficacy of ALK5 inhibition in myelofibrosis
Yue, L., Bartenstein, M., Zhao, W., Ho, W. T., Han, Y., Murdun, C., Mailloux, A. W., Zhang, L., Wang, X., Budhathoki, A., Pradhan, K., Rapaport, F., Wang, H., Shao, Z., Ren, X., Steidl, U., Levine, R. L., Zhao, Z. J., Verma, A. & Epling-Burnette, P. K., Apr 6 2021, In: Journal of Clinical Investigation. 2, 7, e90932.
Research output: Contribution to journal › Article › peer-review

Open Access
14 Scopus citations
Excessive R-loops trigger an inflammatory cascade leading to increased HSPC production
Weinreb, J. T., Ghazale, N., Pradhan, K., Gupta, V., Potts, K. S., Tricomi, B., Daniels, N. J., Padgett, R. A., De Oliveira, S., Verma, A. & Bowman, T. V., Mar 8 2021, In: Developmental cell. 56, 5, p. 627-640.e5
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
First-in-human study of inhaled Azacitidine in patients with advanced non-small cell lung cancer
Cheng, H., Zou, Y., Shah, C. D., Fan, N., Bhagat, T. D., Gucalp, R., Kim, M., Verma, A., Piperdi, B., Spivack, S. D., Halmos, B. & Perez-Soler, R., Apr 2021, In: Lung Cancer. 154, p. 99-104 6 p.
Research output: Contribution to journal › Article › peer-review
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism
Ueda, K., Kumari, R., Schwenger, E., Wheat, J. C., Bohorquez, O., Narayanagari, S. R., Taylor, S. J., Carvajal, L. A., Pradhan, K., Bartholdy, B., Todorova, T. I., Goto, H., Sun, D., Chen, J., Shan, J., Song, Y., Montagna, C., Xiong, S., Lozano, G., Pellagatti, A. & 3 others, Boultwood, J., Verma, A. & Steidl, U., Apr 12 2021, In: Cancer Cell. 39, 4, p. 529-547.e7
Research output: Contribution to journal › Article › peer-review